top of page

Dr Moses is a Neurologist and Fellow of the Royal Australasian College of Physicians.

​

ANZAN-accredited Level 3 EMG supervisor.

 

David is a senior neurologist at Monash Medical Centre. He completed a clinical and neurophysiology fellowship at St. Vincent's Hospital and was a VMO at St. Vincent's Public Hospital. 

 

While no longer active in research, David previously worked in the laboratory of Prof John Finberg, helping to develop Azilect, a medication for Parkinson's disease and subsequently in the laboratory of Prof Mal Horne and Prof John Drago, Howard Florey Institute, working on developing new strategies for treating Parkinson's disease.

​

Dr Moses actively participates in the RACP-accredited CME program. He is a full member of the Australian and New Zealand Association of Neurologists, the American Association of Neuromuscular & Electrodiagnostic Medicine and The International Parkinson and Movement Disorder Society. He participates in undergraduate and postgraduate teaching and registrar's training at Monash Neurology.

 

​

​

​

 

​

​

Selected publications in peer-reviewed journals:

 

Frugier T, Conquest A, McLean C, Currie P, Moses D, Goldshmit Y. Expression and activation of EphA4 in the human brain after traumatic injury. J Neuropathol Exp Neurol. 2012 Mar;71(3):242-50.

​

 

Plummer C, Vogrin S, Cook M, Moses D. Curing of oscillating larynx by levetiracetam. Arch Neurol. 2011 Aug;68(8):1075

​

​

Fernando, CV, Moses, D, Parish CL, Thomas D, Drago, J, Horne, M. K., Creating a Ventral Midbrain Stem Cell Niche in an Animal Model for Parkinson's Disease. Stem Cells Dev, 2010 Apr 23 

​

​

George JL, Mok S, Moses D, Wilkins S, Bush AI, Cherny RA, Finkelstein DI, Targeting the progression of Parkinson's disease. Curr Neuropharmacol. 2009 Mar;7(1):9-36

​

​

Moses, D, Drago, J, Teper, Y, Gantois, I., Finkelstein, D. I., Horne, M. K., Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo. Neuroscience, Available online 8 April 2008

​

​

Nisbet DR, Moses D, Gengenbach TR, Forsythe JS, Finkelstein DI, Horne MK., Enhancing neurite outgrowth from primary neurones and neural stem cells using thermoresponsive hydrogel scaffolds for the repair of spinal cord injury.J Biomed Mater Res A. 2008 Apr 10; [Epub ahead of print] PMID: 18404707 [PubMed – as supplied by publisher]

 

 

Moses, D, Teper, Y., Gantois, I., Finkelstein, D. I., Horne, M. K., and Drago, J. 2006. Murine embryonic EGF-responsive ventral mesencephalic neurospheres display distinct regional specification and promote survival of dopaminergic neurons. Exp Neurol 199: 209-221.

 

 

Moses D, Gross A, Finberg J.P.M. 2004 Rasagiline enhances LDOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea pig. Neuropharmacology.Jul;47(1):72-80.

bottom of page